Recent Updates on Corals from Nephtheidae.

Area of Science:

• Marine natural products chemistry
• Pharmacological screening
• Drug discovery and development

Background:

• Marine organisms, particularly soft corals, are prolific sources of bioactive secondary metabolites.
• The family Nephtheidae is recognized for yielding compounds with diverse pharmaceutical applications.
• Cembranoids and sterols from soft corals have demonstrated anticancer, antidiabetic, anti-osteoporosis, anti-inflammatory, and antituberculosis activities.

Purpose of the Study:

• To provide a comprehensive review of metabolites isolated from the Nephtheidae family between 2011 and November 2018.
• To document the natural sources and known biological potential of these metabolites.
• To underscore the importance of marine soft corals in identifying novel drug leads.

Main Methods:

• Literature search and compilation of data on metabolites from Nephtheidae soft corals.
• Analysis of reported chemical structures and biological activities.
• Categorization of compounds based on their chemical class and pharmacological effects.

Main Results:

• A wide array of secondary metabolites, including cembranoids and sterols, were identified from Nephtheidae soft corals.
• These metabolites exhibit a broad spectrum of biological activities relevant to various therapeutic areas.
• The review covers metabolites isolated from 2011 to November 2018, detailing their sources and bioactivities.

Conclusions:

• Marine soft corals of the Nephtheidae family are a valuable resource for discovering novel bioactive compounds.
• Continued investigation into these organisms holds significant promise for pharmaceutical innovation.
• The documented metabolites and their activities provide a foundation for future drug development efforts.